Nutrients (Sep 2022)

Randomized Trial of Early Enhanced Parenteral Nutrition and Later Neurodevelopment in Preterm Infants

  • Erin E. Morris,
  • Neely C. Miller,
  • Nicholas A. Marka,
  • Jennifer L. Super,
  • Emily M. Nagel,
  • Juan David Gonzalez,
  • Ellen W. Demerath,
  • Sara E. Ramel

DOI
https://doi.org/10.3390/nu14193890
Journal volume & issue
Vol. 14, no. 19
p. 3890

Abstract

Read online

Retrospective studies indicate that the parenteral provision of calories, proteins, and lipids in the first week of life is associated with improved later neurodevelopment. We aimed to determine whether infants randomized to an enhanced parenteral nutrition protocol had improved developmental outcomes at 4, 12, or 24 months corrected age (CA). In total, 90 preterm infants (n = 33) and the Bayley Scales of Infant Development (BSID) at 12 (n = 46) and 24 (n = 29) months CA. P100 latency was longer in the intervention group, indicating slower processing speed (145 vs. 178 ms, p = 0.01). This association did not hold in multivariable analysis adjusting for potentially confounding variables. BSID scores were not associated with enhanced PN. Higher enteral energy and protein intake regardless of randomization group were associated with faster processing speed at 4 months CA (p ≤ 0.02 for both). Enhanced early PN was not associated with improved neurodevelopment; however, first-week enteral caloric and protein intake were associated with improved speed of processing.

Keywords